Effects of Pioglitazone on Asymmetric Dimethylarginine and Components of the Metabolic Syndrome in Nondiabetic Patients (EPICAMP Study): A Double-Blind, Randomized Clinical Trial

The present trial aimed to investigate the effects of pioglitazone on the serum level of asymmetric dimethylarginine (ADMA), a marker of endothelial function, and some indices of inflammation and glucose and lipid metabolism in nondiabetic metabolic syndrome patients. 104 eligible participants (57%...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Shokouh, Pedram, Joharimoghadam, Adel, Roohafza, Hamidreza, Sadeghi, Masoumeh, Golabchi, Allahyar, Boshtam, Maryam, Sarrafzadegan, Nizal
פורמט: Artigo
שפה:Inglês
יצא לאור: Hindawi Publishing Corporation 2013
נושאים:
Clinical Study
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654334/
https://ncbi.nlm.nih.gov/pubmed/23710164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/358074
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים